Vigabatrin en es it fr

Vigabatrin Brand names, Vigabatrin Analogs

Vigabatrin Brand Names Mixture

  • No information avaliable

Vigabatrin Chemical_Formula


Vigabatrin RX_link

No information avaliable

Vigabatrin fda sheet

Vigabatrin msds (material safety sheet)

Vigabatrin Synthesis Reference

No information avaliable

Vigabatrin Molecular Weight

129.157 g/mol

Vigabatrin Melting Point

No information avaliable

Vigabatrin H2O Solubility

55.1 mg/mL

Vigabatrin State


Vigabatrin LogP


Vigabatrin Dosage Forms

Powder (500 mg sachets); Tablet (500 mg)

Vigabatrin Indication

For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.

Vigabatrin Pharmacology

Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.

Vigabatrin Absorption

Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.

Vigabatrin side effects and Toxicity

No information avaliable

Vigabatrin Patient Information

This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.

Vigabatrin Organisms Affected

Humans and other mammals